
Researchers at IASST and IIT-Guwahati have developed 'RK-251', a smart drug designed to target aggressive breast cancer cells while minimizing side effects.
The drug is being hailed as a potential breakthrough that could eventually replace traditional chemotherapy, which often causes significant damage to healthy tissues.
Clinical trials are expected to begin by late 2026, with the Department of Science and Technology providing the necessary funding to accelerate the development process.